Dehydrocholic acid/homatropine

Peptide corresponding to sequence numbers 116-131of the human alpha synuclein molecule. Application For use in blocking the reactivity of AB5334P.

A sulfated form of taurocholic acid that may be involved in the elimination and detoxification of bile acids during hepatobiliary diseases.

Non-reducing disaccharide that yields 2 moles of D-glucose upon acid hydrolysis. Inhibits polyglutamine-mediated protein aggregation both in vivo and in vitro .

Non-reducing disaccharide that yields 2 moles of D-glucose upon acid hydrolysis. Inhibits polyglutamine-mediated protein aggregation both in vivo and in vitro .

A stable analog of PGH2 that inhibits both PGI and TX synthases with more selectivity towards PGI synthase a partial agonist at TP receptors.

A stable analog of PGH2 that inhibits both PGI and TX synthases with more selectivity towards PGI synthase a partial agonist at TP receptors.

Vanillylmandelic acid-d 3 is the deuterium labeled Vanillylmandelic acid. Vanillylmandelic acid is the endproduct of epinephrine and norepinephrine metabolism. Vanillylmandelic acid can be used as an indication of the disorder in neurotransmitter

Vanillylmandelic acid-d 3 is the deuterium labeled Vanillylmandelic acid. Vanillylmandelic acid is the endproduct of epinephrine and norepinephrine metabolism. Vanillylmandelic acid can be used as an indication of the disorder in neurotransmitter

inhibiting α-synuclein toxicity.

inhibiting α-synuclein toxicity.

inhibiting α-synuclein toxicity.

inhibiting α-synuclein toxicity.